BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark WF, Huang SS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM. Plasmapheresis for the treatment of kidney diseases. Kidney International 2016;90:974-84. [DOI: 10.1016/j.kint.2016.06.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Boser M, Kielstein JT. [Role of plasmapheresis and immunoadsorption in salvage therapy of rheumatological diseases]. Z Rheumatol 2016;75:964-72. [PMID: 27807630 DOI: 10.1007/s00393-016-0219-7] [Reference Citation Analysis]
2 Kronbichler A. Therapeutic Plasma Exchange Strategy in Complement-Mediated Diseases: An Overview. Ther Apher Dial 2018;22:8-10. [PMID: 29405620 DOI: 10.1111/1744-9987.12640] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Alamartine E, Maillard N. Therapeutic plasma exchange in nephrology. Where it applies? Transfusion and Apheresis Science 2019;58:262-5. [DOI: 10.1016/j.transci.2019.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Namikawa A, Shibuya Y, Ouchi H, Takahashi H, Furuto Y. A case of ABO-incompatible blood transfusion treated by plasma exchange therapy and continuous hemodiafiltration. CEN Case Rep 2018;7:114-20. [PMID: 29383577 DOI: 10.1007/s13730-018-0307-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Apaydin S. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis. Transfus Apher Sci. 2018;57:8-12. [PMID: 29503131 DOI: 10.1016/j.transci.2018.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ranganathan D, John GT. Therapeutic Plasma Exchange in Renal Disorders. Indian J Nephrol 2019;29:151-9. [PMID: 31142960 DOI: 10.4103/ijn.IJN_420_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34:171-354. [PMID: 31180581 DOI: 10.1002/jca.21705] [Cited by in Crossref: 314] [Cited by in F6Publishing: 277] [Article Influence: 104.7] [Reference Citation Analysis]
8 Hellmich B, Löffler C. [What are the indications for rescue procedures? : Systemic rheumatic diseases in the intensive care unit]. Z Rheumatol 2019;78:955-66. [PMID: 31485728 DOI: 10.1007/s00393-019-00687-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Cheungpasitporn W, Thongprayoon C, Mao MA, Boonpheng B, Bathini T, Vallabhajosyula S, Medaura J, Chewcharat A, Kanduri SR, Kovvuru K, Salim SA, Kaewput W. The impact of race on hospitalization outcomes for goodpasture's syndrome in the United States: nationwide inpatient sample 2003-2014. Hosp Pract (1995) 2021;49:22-6. [PMID: 32981378 DOI: 10.1080/21548331.2020.1828887] [Reference Citation Analysis]
10 Claudel SE, Tucker BM, Kleven DT, Pirkle JL Jr, Murea M. Narrative Review of Hypercoagulability in Small-Vessel Vasculitis. Kidney Int Rep 2020;5:586-99. [PMID: 32405580 DOI: 10.1016/j.ekir.2019.12.018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lim E, Kim Y, Jeong JC, Park I, Kim H, Lee SH, Oh CK, Shin GT. Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation. Kidney Res Clin Pract 2017;36:192-9. [PMID: 28680827 DOI: 10.23876/j.krcp.2017.36.2.192] [Reference Citation Analysis]
12 de Sousa MV, Fernandes LGR, de Freitas LLL, Zollner RDL, Mazzali M. De Novo Membranous Nephropathy Associated With Antibody-Mediated Rejection in Kidney Transplant Recipients. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.11.041] [Reference Citation Analysis]
13 Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab. BMC Nephrol 2018;19:361. [PMID: 30558559 DOI: 10.1186/s12882-018-1177-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Stummvoll G, Aringer M, Handisurya A, Derfler K. Immunoadsorption in Autoimmune Diseases Affecting the Kidney. Seminars in Nephrology 2017;37:478-87. [DOI: 10.1016/j.semnephrol.2017.05.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
15 Caeiro Alves F, Aguiar R, Pessegueiro P, Pires C. Thrombotic microangiopathy associated with Mycoplasma pneumoniae infection. BMJ Case Rep 2018;2018:bcr-2017-222582. [PMID: 29550758 DOI: 10.1136/bcr-2017-222582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Kim JS, Lee JY, Yang JW, Lee KH, Effenberger M, Szpirt W, Kronbichler A, Shin JI. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 2021;11:316-29. [PMID: 33391477 DOI: 10.7150/thno.49713] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 35.0] [Reference Citation Analysis]
17 Clark WF, Patriquin C, Licht C, Huang SH, Rock G. Simple diagnosis and treatment algorithm for adult thrombotic microangiopathy. Transfus Apher Sci 2017;56:50-1. [PMID: 28139433 DOI: 10.1016/j.transci.2016.12.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Yap BJM, Lai-Foenander AS, Goh BH, Ong YS, Duangjai A, Saokaew S, Chua CLL, Phisalprapa P, Yap WH. Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine. Front Cardiovasc Med 2021;8:732369. [PMID: 34621800 DOI: 10.3389/fcvm.2021.732369] [Reference Citation Analysis]
19 Bai Z, Chen Y, Dong L. Experience of therapeutic plasma exchange in rheumatic diseases: Albumin may be a suitable substitute for plasma. Arch Rheumatol 2021;36:398-408. [PMID: 34870172 DOI: 10.46497/ArchRheumatol.2021.8447] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lozano M, Rivero A, Cid J. Plasma exchange activity in the European Union. Transfus Apher Sci 2019;58:278-80. [PMID: 31029611 DOI: 10.1016/j.transci.2019.04.013] [Reference Citation Analysis]
21 Fernández-zarzoso M, Gómez-seguí I, de la Rubia J. Therapeutic plasma exchange: Review of current indications. Transfusion and Apheresis Science 2019;58:247-53. [DOI: 10.1016/j.transci.2019.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
22 Lee H, Kang E, Kang HG, Kim YH, Kim JS, Kim HJ, Moon KC, Ban TH, Oh SW, Jo SK, Cho H, Choi BS, Hong J, Cheong HI, Oh D. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Korean J Intern Med. 2020;35:25-40. [PMID: 31935318 DOI: 10.3904/kjim.2019.388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Zanatta E, Cozzi M, Marson P, Cozzi F. The role of plasma exchange in the management of autoimmune disorders. Br J Haematol 2019;186:207-19. [PMID: 30924130 DOI: 10.1111/bjh.15903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]